Martin Shkreli

American financial investor and businessman (born 1983)

Martin Shkreli (born March 17, 1983) is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016. In September 2015, Shkreli was widely criticized when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price to insurance companies from $13.50 to $750.00 (USD) per pill, sparking a scandal in the United States and around the world, cementing his reputation as 'the most hated man in America'.

From Wikipedia, under CC BY-SA. More on occurri.